Passive diffusion vs. active pH-dependent encapsulation of tyrosine kinase inhibitors vandetanib and lenvatinib into folate-targeted ferritin delivery system

INTERNATIONAL JOURNAL OF NANOMEDICINE

ŠKUBALOVÁ, Z.; REX, S.; SÚKUPOVÁ, M.; ZAHÁLKA, M.; SKLÁDAL, P.; PŘIBYL, J.; MICHÁLKOVÁ, H.; WEERASEKERA, A.; ADAM, V.; HEGER, Z., 2021: Passive diffusion vs. active pH-dependent encapsulation of tyrosine kinase inhibitors vandetanib and lenvatinib into folate-targeted ferritin delivery system. INTERNATIONAL JOURNAL OF NANOMEDICINE , p. 1 - 14, doi: 10.2147/IJN.S275808; FULL TEXT

Research Groups:

• Smart Nanodevices - Vojtěch Adam
• Nanobiotechnology - Petr Skládal
• CF: Nanobiotechnology Core Facility

CEITEC authors:

• Prof. Vojtěch Adam, Ph.D.
• Zbyněk Heger, Ph.D.
• Petr Skládal
• Jan Přibyl, Ph.D.